CONMED Appoints Experienced CFO John Gallagher from Certara, Strengthening Financial Leadership
CNMD is trading near its 52-week low of $31.84 (0.8% above the low) on elevated volume (2.0× avg).
Summary
CONMED Corporation has appointed John E. Gallagher, formerly CFO of Certara, Inc. and Cue Health Inc., as its new Executive Vice President and Chief Financial Officer, effective July 15, 2026. This hire brings significant healthcare and public company financial expertise to CONMED.
Key Events · Executive and Board Changes · CNMD
-
New CFO Appointment
John E. Gallagher has been appointed Executive Vice President, Chief Financial Officer, effective July 15, 2026. He will also serve as the principal financial and accounting officer.
-
Experienced Financial Leader
Mr. Gallagher brings nearly three decades of financial experience, having served as CFO of Certara, Inc. and Cue Health Inc., and held senior finance roles at Becton, Dickinson & Co., General Electric, and Ford Motor Company.
-
Significant Compensation Package
His compensation includes an annual base salary of $650,000, an 85% target annual cash bonus, and equity grants totaling $3.8 million, including a $1.5 million make-whole RSU grant for forfeited awards from a prior employer.
-
Transition of Interim Officers
Patrick Beyer will cease to be Interim Principal Financial Officer but continues as President and CEO. Kimberly Lockwood will cease to be Interim Principal Accounting Officer, remaining Interim Corporate Controller.
Analysis · CNMD · Industrial Applications And Services
The appointment of a seasoned CFO like John Gallagher is a critical positive development for CONMED, especially following the recent departure of its Interim PFO and ongoing efforts to manage significant convertible note debt. Gallagher's extensive background in medical technology and public company finance, including roles at Becton Dickinson, Certara, and Cue Health, provides crucial stability and strategic leadership to the company's financial operations. This move signals a commitment to strengthening the executive team and addressing financial complexities, which is particularly important as the stock trades near its 52-week low.
At the time of this filing, CNMD was trading at $32.11 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $966.8M. The 52-week trading range was $31.84 to $56.64. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.